Clinical Trials
Tallac Reveal They Have Served Their First TAC-001 Patient
In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has received treatment with TAC-001. TAC-001 is the first clinical candidate from the company's innovative toll-like...
Drug Research
September May Bring Updated COVID-19 Booster Shots To Market
According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus subvariants may be made accessible in the early fall, subject to approval by federal health...
Drug Research
Zoryve Cream By Arcutis Receives FDA Approval For Psoriasis
Pfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment never took off because of adverse reactions and funding problems. Arcutis Biotherapeutics, a young biotech company, is now introducing...
Drug Research
Issues With Accelerated Approval Remain A Problem For FDA
The use of excessively fragile efficacy data and delays in sponsors' presenting living proof from post-approval trials, as well as the approval of some crucial drugs based on preliminary clinical evidence, continue to be controversial issues. Under the programme,...
Drug Research
The Ratio of NA To NAM As A Test For Cell Therapy Sterility
According to research, the ratio of nicotinic acid (NA) to nicotinamide (NAM) considerably rises when living microorganisms are present inside 24 hours. This ratio can be used as a biomarker to identify microbial contamination in cell therapies at an...
IT & Data Management
Regulators Agree To Work Together On The Unification of RWE
Real-world evidence (RWE) should be included in regulatory decision-making, according to a declaration backed by both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The International Coalition of Medicines Regulatory Authorities (ICMRA) released a...
Drug Research
Pfizer Is Committed To Paxlovid Role In Stalling COVID-19
Pfizer is prepared and equipped to continue its pandemic sales supremacy, the company's chief executive said on a July 28Â investor call, even if federal contracts for COVID-19 antivirals and vaccines dry up.
During the company's second-quarter earnings call, CEO Albert...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read